Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection

被引：4
作者：
Larry M. Baddour
机构：
来源：
Current Infectious Disease Reports | 2002年 / 4卷 / 5期
关键词：
Adjunctive Therapy; Lenograstim; Amputation Rate; Prospective Control Trial; Peripheral Leukocyte Count;
D O I：
10.1007/s11908-002-0007-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：413 / 414
页数：1
相关论文
共 13 条
  • [1] Souza LM(1986)Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells Science 232 61-65
  • [2] Boone TC(1997)Randomized placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection Lancet 350 855-859
  • [3] Gabrilove J(1993)Evidence of ex vivo and in vivo impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus Diabetes Res Clin Pract 19 183-188
  • [4] Gough A(2001)Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection Diabetes Obes Metab 3 332-337
  • [5] Clapperton M(undefined)undefined undefined undefined undefined-undefined
  • [6] Rolando N(undefined)undefined undefined undefined undefined-undefined
  • [7] Marphhoffer W(undefined)undefined undefined undefined undefined-undefined
  • [8] Stein M(undefined)undefined undefined undefined undefined-undefined
  • [9] Schleinkofer L(undefined)undefined undefined undefined undefined-undefined
  • [10] Frederlin K(undefined)undefined undefined undefined undefined-undefined
12